These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401 [TBL] [Abstract][Full Text] [Related]
7. The reply. Vieweg WV; Hasnain M; Howland RH Am J Med; 2013 Jun; 126(6):e23. PubMed ID: 23684406 [No Abstract] [Full Text] [Related]
8. Citalopram, escitalopram: no more effective than other SSRIs, but more toxic. Prescrire Int; 2016 Apr; 25(170):98. PubMed ID: 27186623 [No Abstract] [Full Text] [Related]
9. Torsade de Pointes episodes under treatment with selective serotonin reuptake inhibitors. Wenzel-Seifert K; Wittmann M; Haen E Pharmacopsychiatry; 2010 Nov; 43(7):279-81. PubMed ID: 20927699 [No Abstract] [Full Text] [Related]
10. A critical evaluation of the cardiac toxicity of citalopram: part 1. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855 [TBL] [Abstract][Full Text] [Related]
11. Towards limiting QT interval prolongation and arrhythmia risk in citalopram use. Zhang Y; Baranchuk A; Hancox JC Cardiol J; 2014; 21(5):454-7. PubMed ID: 25434987 [No Abstract] [Full Text] [Related]
12. Prolonged QTc interval and torsades de pointes induced by citalopram. Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232 [TBL] [Abstract][Full Text] [Related]
13. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease. de Gregorio C; Morabito G; Cerrito M; Dattilo G; Oreto G Int J Cardiol; 2011 Apr; 148(2):226-8. PubMed ID: 19540606 [No Abstract] [Full Text] [Related]
14. An electrocardiograph should be examined in patients with a hypersensitive esophagus before a trial of citalopram. Lee TH; Lee JS Am J Gastroenterol; 2013 May; 108(5):854. PubMed ID: 23644968 [No Abstract] [Full Text] [Related]
15. QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine. Manini AF; Raspberry D; Hoffman RS; Nelson LS J Med Toxicol; 2007 Dec; 3(4):178-81. PubMed ID: 18072173 [No Abstract] [Full Text] [Related]
16. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study. Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445 [TBL] [Abstract][Full Text] [Related]
17. QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine. Wilting I; Smals OM; Holwerda NJ; Meyboom RH; de Bruin ML; Egberts TC Am J Psychiatry; 2006 Feb; 163(2):325. PubMed ID: 16449492 [No Abstract] [Full Text] [Related]
18. A question about the potential cardiac toxicity of escitalopram. Howland RH J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011 [TBL] [Abstract][Full Text] [Related]
19. Exacerbation of idiopathic priapism with risperidone-citalopram combination. Freudenreich O J Clin Psychiatry; 2002 Mar; 63(3):249-50. PubMed ID: 11926728 [No Abstract] [Full Text] [Related]
20. Sulpiride-associated torsade de pointes in a woman with bipolar disorder. Teng PR; Shen TY; Lai TJ Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253 [No Abstract] [Full Text] [Related] [Next] [New Search]